These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 31166016)
41. Contact dermatitis caused by glucose sensors, insulin pumps, and tapes: Results from a 5-year period. Ahrensbøll-Friis U; Simonsen AB; Zachariae C; Thyssen JP; Johansen JD Contact Dermatitis; 2021 Feb; 84(2):75-81. PubMed ID: 32677709 [TBL] [Abstract][Full Text] [Related]
42. Treatment of generalised isobornyl acrylate contact allergy from diabetes pump with Dupilumab. Arasu A; Ross G Australas J Dermatol; 2022 Feb; 63(1):e91-e93. PubMed ID: 34751430 [No Abstract] [Full Text] [Related]
43. Sensitization to isobornyl acrylate in a tertiary Belgian hospital. Herman A; Baeck M Contact Dermatitis; 2021 Jul; 85(1):105-106. PubMed ID: 33527358 [No Abstract] [Full Text] [Related]
44. Patch Testing with Isobornyl Acrylate in 16 Swedish Patients with Contact Dermatitis from Glucose Sensors and/or Insulin Pumps. Mowitz M; Fornander L; Hosseiny S; Ryberg K; Bruze M Acta Derm Venereol; 2019 Dec; 99(13):1286-1287. PubMed ID: 31289841 [No Abstract] [Full Text] [Related]
45. Patch test sensitization to Compositae mix, sesquiterpene-lactone mix, Compositae extracts, laurel leaf, Chlorophorin, Mansonone A, and dimethoxydalbergione. Kanerva L; Estlander T; Alanko K; Jolanki R Am J Contact Dermat; 2001 Mar; 12(1):18-24. PubMed ID: 11244135 [TBL] [Abstract][Full Text] [Related]
46. Isobornyl acrylate and diabetic devices steal the Show for the 2020 American Contact Dermatitis Society Allergen of the Year. Nath N; Reeder M; Atwater AR Cutis; 2020 Jun; 105(6):283-285. PubMed ID: 32716991 [TBL] [Abstract][Full Text] [Related]
47. Allergic contact dermatitis caused by isobornyl acrylate in two patients treated for idiopathic pulmonary arterial hypertension. Malinauskiene L; Šlekyte G; Mowitz M; Isaksson M; Zablockis R Contact Dermatitis; 2020 Aug; 83(2):170-171. PubMed ID: 32432364 [No Abstract] [Full Text] [Related]
48. Allergic contact dermatitis caused by a glucose monitoring system: an emerging side-effect of diabetes medical devices. Tramontana M; Hansel K; Bianchi L; Agostinelli D; Stingeni L J Eur Acad Dermatol Venereol; 2020 May; 34(5):e223-e225. PubMed ID: 31904884 [No Abstract] [Full Text] [Related]
49. Allergic contact dermatitis caused by a new insulin pump system containing isobornyl acrylate. Enberg J; Hamnerius N; Mowitz M Contact Dermatitis; 2023 Apr; 88(4):326-328. PubMed ID: 36607276 [No Abstract] [Full Text] [Related]
50. Allergic contact dermatitis caused by dipropylene glycol diacrylate in the Omnipod® insulin pump. Ulriksdotter J; Svedman C; Bruze M; Mowitz M Br J Dermatol; 2022 Feb; 186(2):334-340. PubMed ID: 34510410 [TBL] [Abstract][Full Text] [Related]